The Fed Doesn't Set Your Next Round's Terms

The attractive thing about waiting for the Federal Reserve is that nobody on your team has to make an awkward phone call. You can describe the delay as macro discipline, put a chart in the board deck, and let an institution with its own press room take responsibility for your fundraising calendar. Payroll will continue asking you personally.

Should a founder wait for lower rates before raising? Sometimes. A company with ample cash and a near-term milestone may reasonably choose to wait. But the expected benefit needs to survive comparison with the cash consumed, the risk that financing remains unavailable, and the negotiating options that expire during the delay.

This matters after a weak jobs report because a plausible market observation can become a company decision without anyone pricing the journey between them. Rates might improve. Your company might arrive at that improvement with fewer alternatives and a considerably more accommodating attitude toward investor preferences.

A jobs release can change market expectations in minutes. Your investor's investment committee remains free to request another customer call. Those two speeds belong in different parts of the fundraising plan.

On October 2, 2026, the Bureau of Labor Statistics reported that nonfarm payrolls increased by 29,000 in September, while unemployment was 4.2%, compared with 4.1% in August. July and August payroll gains were revised down by a combined 60,000. Payroll employment and unemployment come from separate establishment and household surveys; they describe different aspects of the labour market.¹

Reuters reported that the release pushed expectations of an October Federal Reserve rate increase lower. It also reported economists' caution that seasonal adjustment and the late Labour Day holiday could help explain the weak payroll figure. That was an explanation offered for the data, rather than proof that the slowdown would disappear.²

The distinction matters: a reduced chance of a hike is different from a promised cut. Neither establishes what an investor will pay for your shares. BLS also revises initial payroll estimates as more reports arrive and seasonal factors are recalculated.¹ Building an irreversible cash decision around a first estimate gives a provisional number a surprisingly senior job at your company.

Use the release to update scenarios. If your plan requires a specific policy decision, record what happens if that decision fails to arrive. If the plan still works with unchanged rates, the macro view is useful context. If it fails, you have made a financing bet that deserves an explicit limit.

Ignoring monetary policy would be just as convenient as blaming it for everything. A founder can get an entire board meeting out of either position without discussing customer retention.

The Federal Reserve explains that monetary policy influences broader interest rates, asset prices, credit conditions, and spending. Expectations about future policy also affect financial conditions. That means markets can respond before an actual rate decision, and a decision that was already expected need not deliver a fresh improvement when announced.³

There is evidence that this reaches venture capital. In their September 2023 working paper, Monetary Policy and Innovation, Yueran Ma and Kaspar Zimmermann estimate that a monetary tightening shock of 100 basis points reduces venture investment by about 25% over the following one to three years. They identify both demand and financial conditions as relevant channels.⁴

That is an aggregate research estimate over years. It does not say that reversing the shock lifts your valuation by 25%, or that postponing a Series A until the next meeting produces a better offer. The paper supports taking the environment seriously; it supplies no delivery date for your term sheet.

The transmission can also pull in opposite directions. Lower required returns can support valuations, all else equal. But if easier policy accompanies deteriorating demand, a startup may face weaker revenue prospects at the same time. The financing question includes what is happening to customers, as well as what is happening to the price of money. That is the relevant inference for an operating company.

Nor does an improving venture market distribute its gains evenly. Carta reported that more than 60% of the venture capital raised by companies on its platform in Q1 2026 went to AI companies. That describes a dated quarter and Carta's customer dataset, rather than the entire market.⁵ It is still a useful warning against treating aggregate funding as your available funding.

For your board discussion, use comparable companies at your stage and evidence from investors who actually fund your business model. A record quarter dominated by another category is encouraging in roughly the way your neighbour's kitchen renovation improves your dinner.

Runway becomes bargaining power when it lets you keep operating after declining an offer. It loses much of that value if every available month has already been allocated to a financing process that must succeed. Investors do not need to be villains for this to matter. They can move the discussion to next month's partner meeting. Try offering that scheduling courtesy to payroll.

YC's Dalton Caldwell makes the leverage problem explicit in his advice for companies with less than a year of runway: delay can weaken the company's negotiating position, and founders should not treat continued investor interest or a possible acquisition as a reliable rescue.⁶

Start with unrestricted cash and a cash-flow forecast. Revenue booked is not necessarily cash collected. Include scheduled debt service and known one-off payments. If reducing burn requires severance or contract termination costs, include the cash needed to make the reduction before claiming the savings.

Here is a deliberately simple illustrative scenario, with all amounts in US dollars. A company has US$3.6 million of available cash and constant net burn of US$300,000 a month. It has twelve months until cash reaches zero, assuming no financing or change in operations.

Now assume four months from launching a raise to receiving the money, plus a two-month contingency. These are planning assumptions, not market averages or a recommendation for every company. The latest launch point within this model is six months away:

12 months of runway − 4 months to cash − 2 months of contingency = 6 months before the latest planned launch.

Wait three months, and cash falls to US$2.7 million. Runway becomes nine months. The spare time before that latest launch falls to three months. You consumed a quarter of the runway and half the available delay window.

The contingency exists because diligence can uncover work, a lead can withdraw, or collections can slip. It is a planning margin, not a guarantee of safety. Recalculate it for your own company, particularly if a fallback needs time to implement.

The board can certainly decide to spend three months. It should understand which three months it is spending. Calling all twelve months “flexibility” is how a spreadsheet manages to book the same holiday twice.

Founders often compare today's possible valuation with tomorrow's hoped-for valuation while holding the cheque size constant. This gives patience excellent optics. The cash balance has been quietly removed from the photograph.

Continue the hypothetical. Suppose a raise begun now could bring in US$6 million at US$24 million pre-money. New investors would own 6 ÷ (24 + 6), or 20% of the company immediately after the round. Existing holders collectively retain 80%. This is the basic priced-round calculation; a real cap table also needs any convertibles and option-pool changes.⁷

A three-month delay consumes US$900,000 at the assumed burn. If the objective is to reach the same cash balance at the eventual closing as the earlier financing would provide at its closing, the delayed raise needs to be US$6.9 million. Assume both processes take the same time to close and burn stays constant. Their common closing lag cancels out; the extra three months remain a cost.

At an unchanged US$24 million pre-money valuation, that larger raise sells approximately 22.33%. To keep dilution at the original 20%, the company needs US$27.6 million pre-money, a 15% increase. The calculation is 6.9 ÷ (27.6 + 6.9) = 20%.

At US$36 million pre-money, the delayed US$6.9 million raise sells about 16.08%. That would improve on today's assumed deal. The question is whether you have evidence for the improvement, and enough margin if the evidence disappoints.

The interactive comparison keeps the original 20% deal visible beside the delayed raise at each authored valuation. It excludes fees, taxes, debt changes, convertibles, pool increases, and differences in investor rights. It is arithmetic for a controlled scenario, not a forecast linking rates to valuations.

You could instead keep the delayed raise at US$6 million. At US$36 million pre-money, dilution would be about 14.29%. You would also arrive at closing with US$900,000 less cash than the earlier path, under these assumptions. That may be acceptable if the intervening work reduced future capital needs. State the changed objective so the board can judge it.

Do not subtract cash burn from a paper valuation uplift and label the result profit. Valuation is a price used to issue shares; it does not pay operating expenses. We can become impressively wealthy in the column immediately beside the one that says we cannot afford November.

For an expected-benefit analysis, assign evidence-based probabilities to financing outcomes and compare the ownership and cash consequences in each. Weight the resulting dilution figures, rather than inserting an average valuation into the dilution formula. Include the possibility of no financing as a separate survival outcome. If the case for waiting only works after assigning failure a probability of zero, reopen the assumptions.

A milestone justifies delay when reaching it changes the risk someone is being asked to finance. “We will have a stronger story” leaves the definition of stronger with the person who would prefer not to start fundraising this week. Conveniently, that person is also presenting the slide.

YC's seed fundraising guide connects readiness to a credible opportunity, product adoption, and a believable plan for what the capital buys.⁷ Translate that principle into the specific objection standing between your company and an investment decision.

Suppose an investor doubts whether pilots become paying deployments. Another three months of pilot announcements may leave that question untouched. A conversion with budget approval, an executed contract, and evidence that deployment costs are manageable could answer it. The value comes from resolving the objection, not from reaching a round number of customer logos.

Write the milestone so an outsider can assess it. Name the evidence required and the person responsible for producing it. Record when the evidence becomes available, including any customer procurement or regulatory step outside your control. Ask suitable investors whether it would materially change their assessment. Their answer is useful market feedback; it remains short of a commitment.

Separate operating progress from financing progress. A release shipped on schedule is operating progress. An investor assigning a partner, completing customer diligence, or explaining the route to approval is financing progress. You may need both before delay becomes attractive.

Also budget the milestone's cost and the financing work that follows it. Spending every remaining dollar to produce excellent evidence leaves nobody funded to show it to the next investor. The milestone can be achieved perfectly while the financing plan fails.

There are sensible reasons to wait: positive cash flow, a genuinely cheap experiment, or a consequential result due soon with enough cash to absorb a miss. The reasoning should remain defensible if rates stay unchanged. Otherwise the milestone risks becoming a costume for a market forecast, complete with its own product manager.

Investor interest becomes leverage when another credible party can actually proceed on a useful timetable. Twelve friendly conversations spread across six months may produce an impressive CRM and no choice at signing. The CRM will congratulate you on the pipeline either way.

Build a process around actual decision capacity. Establish who can sponsor the investment, the remaining diligence, and when the relevant partners can decide. Prepare customer references and consistent financial information early enough that basic cleanup does not consume the period when investors are engaged.

Overlapping conversations can improve your ability to compare offers before selecting a lead. Keep the claims truthful: an introductory meeting is an introductory meeting. Invented competing offers create reputational risk and do nothing to improve the company underneath the process.

The option to decline also deserves an operating plan. What spending can you reduce, on what notice, and with what effect on delivery? Could a smaller round fund a narrower milestone? Would existing investors participate, and on what documented terms? Treat an uncommitted bridge as uncertain capital. A fallback earns its place through feasibility, rather than through the confidence with which someone mentions it at the board meeting.

Then compare the complete bargain. Cooley's term-sheet guidance identifies liquidation economics, board composition, and protective provisions as material negotiating issues. It also warns that exclusivity can bind the company even while much of the proposed investment remains nonbinding.⁸ Have counsel explain the actual scope and duration of any restriction before you sign it.

A higher valuation can come with a larger liquidation preference, a pool increase funded by existing holders, or decision rights that constrain the founder. Compare those consequences explicitly. A headline price cannot tell you who approves the next financing or what common shareholders receive in a modest exit.

Check when the money becomes available, too. NVCA's model financing documents include mechanics for time-based and milestone-based tranches.⁹ If part of the announced round depends on a later condition, your cash forecast needs the actual funding schedule. The press release may have raised the whole amount. Your bank account is waiting for the second episode.

The useful output of a macro discussion is a decision someone can later evaluate. “We are monitoring conditions” is an excellent description of a television left on in reception. A financing plan needs an owner and a trigger.

Before postponing the raise, write a short waiting memo for the board. Put the current financing alternatives beside the proposed delay. Distinguish an executable offer from indicative feedback; both contain information, but only one has terms you can meaningfully compare.

The memo should answer:

1. What do we expect to improve? Name the milestone or financing condition, the evidence behind the expectation, and who would need to value it.
2. What will the wait cost? Show forecast cash consumption, incremental spending, and the effect on the funding amount needed at closing.
3. What is left if we are wrong? Model unchanged conditions and a worse outcome, including a failed raise and the time needed for a feasible fallback.
4. When do we act anyway? Set a launch date or cash threshold that ends the delay, with a named person responsible for starting the process.

Make the fallback's lead time part of that trigger. A cost reduction that takes two months to implement cannot rescue a plan that first considers it during the final payroll cycle. Review the forecast as collections and spending change, rather than letting the original budget retain ceremonial authority.

Investors recommending patience can be helpful. Ask what specific evidence they expect to see and whether they can make a financing decision when it arrives. A board member can recommend another quarter of patience in the time it takes to unmute Zoom. The company gets the three-month invoice.

Put the cash threshold and launch date in the next board minutes. If nobody can name what the delay is expected to buy, start preparing the raise while you still have enough time to reject the answer.